These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15907592)

  • 1. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
    Choi JS; Li X
    Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.
    Choi JS; Jo BW; Kim YC
    Eur J Pharm Biopharm; 2004 Mar; 57(2):313-8. PubMed ID: 15018990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X; Choi JS
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
    Christensen H; Asberg A; Holmboe AB; Berg KJ
    Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of honey on orally and intravenously administered diltiazem kinetics in rabbits.
    Koumaravelou K; Adithan C; Shashindran CH; Asad M; Abraham BK
    Indian J Exp Biol; 2002 Oct; 40(10):1164-8. PubMed ID: 12693698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender related pharmacokinetics of diltiazem in healthy subjects.
    Sáenz-Campos D; Bayés MC; Martin S; Barbanoj MJ; Jané F
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):397-400. PubMed ID: 7582396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of resveratrol on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem, in rats.
    Hong SP; Choi DH; Choi JS
    Cardiovasc Ther; 2008; 26(4):269-75. PubMed ID: 19035878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
    Shin SC; Choi JS; Li X
    Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.
    Choi JS; Han HK
    Int J Pharm; 2005 Nov; 305(1-2):122-8. PubMed ID: 16226412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC; Sams RA; Bonagura JD
    J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced nimodipine bioavailability after oral administration of nimodipine with morin, a flavonoid, in rabbits.
    Choi JS; Burm JP
    Arch Pharm Res; 2006 Apr; 29(4):333-8. PubMed ID: 16681041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diltiazem on the pharmacokinetics of MPC-1304, a new calcium channel blocker.
    Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Shiga T; Ebihara A
    Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):271-4. PubMed ID: 1526689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetic profiles of amlodipine and of a sustained release form of diltiazem.
    Fourtillan JB; Ingrand I; Decourt JP; Istin B; Girault J
    Therapie; 1998; 53(2):121-6. PubMed ID: 9773111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA; Choi DH; Choi JS
    J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits.
    Choi JS; Han HK
    J Pharm Pharmacol; 2004 Dec; 56(12):1537-42. PubMed ID: 15563760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cimetidine on the pharmacokinetics of diltiazem and its main metabolite in rabbits.
    Choi JS; Burm JP
    Arch Pharm Res; 2004 Feb; 27(2):254-8. PubMed ID: 15022730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
    Moon YJ; Morris ME
    Mol Pharm; 2007; 4(6):865-72. PubMed ID: 17970592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Hong SP; Chang KS; Choi DH; Choi JS
    Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats.
    Choi HJ; Choi JS
    Arch Pharm Res; 2005 Aug; 28(8):970-6. PubMed ID: 16178425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.